Tirzepatide (LY3298176) sodium
Products
Description
Tirzepatide (LY3298176, GIP/GLP-1 RA, TZP) sodium is a dual GIP/GLP-1 receptor agonist. Tirzepatide differentially induces internalization of the GIP and GLP-1 receptors with EC50 values of 18.2 nM and 18.1 nM, respectively.
Specifications
| Manufacturer Cat# | P1206 |
|---|---|
| Target | Glucagon Receptor |